Ginkgo Bioworks Holdings (DNA) EBITDA Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | -101.00 |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | -38.00 |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 224.00 |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -463.00 |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 4,868.00 |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -14,185.00 |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 1,247.00 |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -5,330.00 |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -744,940.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14,185.00 |
| Mar 31, 2026 | -15,471.00 |
| Dec 31, 2025 | 2,443.00 |
| Sep 30, 2025 | -16,979.00 |
| Jun 30, 2025 | 24,803.00 |
| Mar 31, 2025 | 25,732.00 |
| Dec 31, 2024 | -16,302.00 |
| Sep 30, 2024 | 45,468.00 |
| Jun 30, 2024 | -16,809.00 |
| Mar 31, 2024 | -20,178.00 |
| Dec 31, 2023 | 16,162.00 |
| Sep 30, 2023 | 46,971.00 |
| Jun 30, 2023 | 21,936.00 |
| Mar 31, 2023 | 13,370.00 |
| Dec 31, 2022 | 89,966.00 |
| Sep 30, 2022 | -95,202.00 |
| Jun 30, 2022 | -31,055.00 |
| Mar 31, 2022 | -27,152.00 |
| Dec 31, 2021 | -96,021.00 |
| Sep 30, 2021 | 22,434.00 |